Steven Boyd
CIK 1706140 · last filed 2022-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.11B
Companies
15
Total Filings
62
Lifetime Open-Market Net
$30.94M
Filer Profile
Reported Address
510 MADISON AVENUE, 7TH FLOORNEW YORK, NY 10022
Related Filers
ARMISTICE CAPITAL, LLC — 239 joint filings, latest 2023-06-28
Armistice Capital Master Fund Ltd. — 232 joint filings, latest 2023-06-28
Cerecor Inc. — 80 joint filings, latest 2023-06-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TENX | Director | 2,330 | $1.86 | $4.3K | $1.54M | 4 | 2022-05-19 |
| AVTX | Director | 16,424 | $16.12 | $264.8K | $39.40M | 3 | 2022-03-07 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 7 | $15.68 | $110 | -$28.46M | 1 | 2021-06-22 |
| Vaxart, Inc. (VXRT) Delisted | Director | 15,600,000 | $0.32 | $4.99M | -$53.29M | 7 | 2020-06-03 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 52,418,772 | $2.93 | $153.59M | $28.90M | 7 | 2020-03-16 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 8,138,000 | — | — | $20.47M | 3 | 2020-01-13 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 0 | — | — | -$1.73M | 4 | 2019-12-23 |
| AYTU | Director | 79,240 | $1.99 | $157.7K | $203.2K | 1 | 2019-12-23 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | Director | 6,260,000 | — | — | $13.27M | 6 | 2019-05-09 |
| BIO-PATH HOLDINGS, INC. (BPTH) Delisted | 10%+ Owner | 12,930 | $0.04 | $453 | -$514.9K | 1 | 2019-01-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 620,000 | — | — | -$5.64M | 2 | 2019-01-14 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 4,336,000 | — | — | -$3.83M | 1 | 2018-08-20 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 34,960,000 | — | — | $16.58M | 7 | 2018-08-20 |
| EYEG | 10%+ Owner | 32,745,000 | $33.99 | $1.11B | $3.96M | 2 | 2018-04-27 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 924,267 | $5.54 | $5.12M | $68.4K | 1 | 2018-02-09 |
Recent Filings · Page 3 of 7
62 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-16 | Avalo Therapeutics, Inc. (CERC) Delisted | Other (J) | −10,365,387 | $0 | EDGAR |
| 2020-02-19 | — | Other (J) | −900,000 | $0 | |
| 2020-02-19 | — | Other (J) | −900,000 | $0 | |
| 2020-01-13 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Mixed | +54,000 | $624.8K | EDGAR |
| 2019-12-23 | Valeritas Holdings Inc. (VLRX) Delisted | Sell (S) | −3,180,000 | -$2.38M | EDGAR |
| 2019-12-23 | AYTU | Buy (P) | +236,364 | $203.2K | EDGAR |
| 2019-11-07 | Vaxart, Inc. (VXRT) Delisted | Buy (P) | +600,000 | $201.8K | EDGAR |
| 2019-10-03 | Vaxart, Inc. (VXRT) Delisted | Buy (P) | +1,308,000 | $451.7K | EDGAR |
| 2019-09-30 | Vaxart, Inc. (VXRT) Delisted | Buy (P) | +21,999,999 | $6.43M | EDGAR |
| 2019-09-18 | — | Buy (P) | +54,549 | $139.9K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.